Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

  1. Budde, L.E.
  2. Sehn, L.H.
  3. Matasar, M.
  4. Schuster, S.J.
  5. Assouline, S.
  6. Giri, P.
  7. Kuruvilla, J.
  8. Canales, M.
  9. Dietrich, S.
  10. Fay, K.
  11. Ku, M.
  12. Nastoupil, L.
  13. Cheah, C.Y.
  14. Wei, M.C.
  15. Yin, S.
  16. Li, C.-C.
  17. Huang, H.
  18. Kwan, A.
  19. Penuel, E.
  20. Bartlett, N.L.
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2022

Volume: 23

Issue: 8

Pages: 1055-1065

Type: Article

DOI: 10.1016/S1470-2045(22)00335-7 GOOGLE SCHOLAR

Sustainable development goals